Ertapenem Intermediate Preparation via Amorphous Precipitation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing Ertapenem intermediate compound 2 with P3 being H result in low purity and poor storage stability, and the use of organic solvents leads to environmental concerns and difficulties in crystallization.
Innovation Solution
A method involving the condensation of the carbapenem parent nucleus with the Ertapenem side chain, followed by pouring the reaction mixture into an aqueous acid solution to obtain the intermediate in amorphous form, which is high in purity and stable for storage, using water as a solvent to avoid organic solvents and reduce inorganic salt introduction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional methods are used to produce Ertapenem intermediate compound 2 with P3 being H, then the synthesis can be completed, but the purity is low and storage stability is poor
Solution Approach 1:
The patent changes the physical state parameter of the product from crystalline to amorphous form by controlling the precipitation process. By adjusting parameters such as temperature, pH, and addition rate during the condensation reaction, the intermediate compound is obtained in amorphous form with high purity and good storage stability, resolving the contradiction between purity and storage stability.
Solution Approach 2:
The patent uses an intermediary approach by introducing a specific base catalyst and controlling the reaction environment to facilitate the formation of amorphous high-purity intermediate. The intermediary role of the base catalyst and reaction conditions enables the transformation from conventional low-purity crystalline form to high-purity amorphous form.
2Ease of manufacture
If organic solvents are used in the synthesis process, then the reaction can proceed, but environmental concerns arise and crystallization is difficult
Solution Approach 1:
The patent substitutes organic solvents with water as the reaction medium, replacing the conventional organic solvent system with an aqueous system. This substitution eliminates environmental pollution issues associated with organic solvents while maintaining reaction feasibility through appropriate base catalyst selection and pH control, achieving both ease of manufacture and environmental sustainability.
3Productivity
If conventional methods are used, then the synthesis can be completed, but inorganic salt introduction increases and crystallization is difficult
Solution Approach 1:
The patent changes the reaction medium parameter from organic to aqueous, which fundamentally alters the solubility and precipitation characteristics. By conducting the reaction in water and controlling pH parameters, the method achieves complete synthesis while minimizing inorganic salt introduction and facilitating the formation of amorphous high-purity intermediate without excessive salt content.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high purity and stability of the Ertapenem intermediate in amorphous form, facilitating industrialization and environmental sustainability by eliminating the need for organic solvents and improving subsequent reaction treatments.
Implementation Method 1
Compound 2 is typically prepared by condensing the carbapenem parent nucleus 3 with the side chain of Ertapenem 4 in the presence of base
Implementation Method 2
when the reaction is finished, the reaction mixture is poured into an aqueous acid solution to yield compound of formula 2a as a solid
Data Source
Figure 1
AI summary
Intermediates of Ertapenem of formula 2a wherein Np represents (I) or (II), and P1 and P2 represent carboxyl protecting groups, and their preparation methods. Compound 2a prepared by the present methods in solid form is amorphous. The present invention also relates to a composition comprising at least 95% of the intermediate of Ertapenem of formula 2a.